Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2017

KAILUA-KONA, Hawaii (February 7, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third quarter and first nine months of fiscal year 2017, ended December 31, 2016. Third Quarter 2017 For the third quarter of fiscal 2017 compared to the third quarter...
Read More

Cyanotech Names Nancy Katz as a Director

KAILUA-KONA, Hawaii (October 25, 2016) — The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Nancy Katz as a Director of the Company. “We are pleased to welcome Ms. Katz to Cyanotech’s Board,” said Michael A. Davis, Chairman of the Board. “Her significant experience as an executive and director of public companies...
Read More

Cyanotech Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin Natural Astaxanthin Products

KAILUA-KONA, Hawaii–(BUSINESS WIRE)–Cyanotech® Corporation (Nasdaq Capital Market: CYAN), is proud to announce that its bulk raw material BioAstin® SCE products have received Non-GMO Project Verification. BioAstin Natural Astaxanthin is a potent natural antioxidant that provides natural support for joint, skin, eye and brain health.* BioAstin is derived from natural microalgae, Haematococcus pluvialis, cultivated and grown...
Read More